Kimia Biosciences Complete Financial Statements
KIMIABL • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Kimia Biosciences (KIMIABL).
Downloads include all available records across all periods.
For market performance, see the
KIMIABL stock price today
.
Profitability Ratios
Net Profit Margin
8.33%
2025 data
EBITDA Margin
18.33%
2025 data
Operating Margin
17.00%
2025 data
Return on Assets
9.01%
2025 data
Return on Equity
100.00%
2025 data
Balance Sheet Ratios
Current Ratio
3.95
2025 data
Debt to Equity
11.10
2025 data
Equity Ratio
9.01%
2025 data
Asset Turnover
1.08
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
+5.8%
Year-over-Year
Net Profit Growth
-20.0%
Year-over-Year
EBITDA Growth
-9.1%
Year-over-Year
Expense Growth
+9.1%
Year-over-Year
Assets Growth
+11.0%
Year-over-Year
Liabilities Growth
+11.0%
Year-over-Year
Operating Cash Flow Growth
+40.0%
Year-over-Year
Investing Cash Flow Growth
-150.0%
Year-over-Year
Financing Cash Flow Growth
-30.8%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 127 | 120 | 107 | 130 | 126 | 135 | 107 | 95 | 77 | 2 | 0 | 2 |
| Expenses | 108 | 99 | 105 | 134 | 124 | 124 | 102 | 88 | 74 | 2 | 4 | 4 |
| EBITDA | 20 | 22 | 1 | -4 | 2 | 11 | 5 | 7 | 3 | 0 | -3 | -1 |
| Operating Profit Margin % | 14.00% | 17.00% | 0.00% | -4.00% | 1.00% | 6.00% | 4.00% | 6.00% | 3.00% | -67.00% | -1759.00% | -110.00% |
| Depreciation | 4 | 3 | 3 | 3 | 3 | 2 | 2 | 1 | 1 | 0 | 0 | 0 |
| Interest | 5 | 5 | 5 | 4 | 4 | 3 | 3 | 2 | 1 | 0 | 1 | 0 |
| Profit Before Tax | 12 | 14 | -7 | -12 | -5 | 6 | 1 | 4 | 2 | -1 | -4 | -2 |
| Tax | -1 | 4 | -2 | -3 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 8 | 10 | -5 | -9 | -4 | 5 | 1 | 4 | 2 | -1 | -4 | -2 |
| Earnings Per Share (₹) | 1.70 | 2.03 | -1.12 | -1.98 | -0.78 | 1.08 | 0.33 | 2.64 | 1.14 | -1.26 | -5.49 | -2.31 |
Related Pages for Kimia Biosciences
Additional stock information and data for KIMIABL
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 111 | 100 | 121 | 110 | 107 | 86 | 65 | 58 | 12 | 4 | 5 |
| Current Assets | 75 | 61 | 83 | 73 | 72 | 61 | 48 | 43 | 2 | 1 | 1 |
| Fixed Assets | 33 | 32 | 34 | 35 | 28 | 18 | 16 | 13 | 7 | 3 | 3 |
| Capital Work in Progress | 0 | 1 | 1 | 0 | 6 | 6 | 2 | 3 | 3 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 78 | 68 | 87 | 74 | 73 | 62 | 48 | 43 | 2 | 1 | 1 |
| LIABILITIES | |||||||||||
| Total Liabilities | 111 | 100 | 121 | 110 | 107 | 86 | 65 | 58 | 12 | 4 | 5 |
| Current Liabilities | 19 | 30 | 40 | 33 | 37 | 34 | 29 | 25 | 9 | 7 | 1 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 10 | 0 | 6 | 15 | 18 | 13 | 6 | 2 | -5 | -4 | 0 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 2 | 2 | 7 | 7 | 7 |
| Reserves & Surplus | 5 | -4 | 1 | 10 | 14 | 9 | 2 | -2 | -12 | -11 | -7 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 21 | 15 | -7 | 8 | 6 | 0 | -3 | -7 | -1 | -6 | 0 |
| Investing Activities | -5 | -2 | -3 | -1 | -14 | -9 | -2 | -2 | -6 | 0 | 0 |
| Financing Activities | -17 | -13 | 10 | -8 | 8 | 9 | 4 | 10 | 7 | 6 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 1 | 0 | 0 | 0 |